The Series A funding will allow TrueFoundry to accelerate its mission towards building a universal platform to develop and ...

Introduction to Digital Health and WellnessThe digital health and wellness industry is experiencing significant growth as healthcare increasingly incorporates technology to improve the quality, ...

Dr. Wimms brings two decades of sleep medicine industry and research expertise to her advisory role at Incannex. Dr. Wimms holds a Doctor of Philosophy (Ph.D.) in Medicine, and Master of Medicine ...

This data feed is not available at this time. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.

In fact, they are more than 10% more likely to start PAP therapy ... Patients can get their myAir scores from the ResMed myAir app. But they can also get them from their Apple watch. They can get ...

周五，在ResMed（NYSE:RMD）公布2025财年第二季度财务业绩后，RBC Capital Markets上调了该公司的目标股价。RBC Capital分析师Craig Wong-Pan将目标价从238.00美元上调至247.00美元，同时维持对该股票的"板块表现"评级。根据InvestingPro数据，ResMed目前交易价格为241.51美元，分析师目标价区间为195美元至295美元。

周五，Stifel分析师维持对ResMed股票（NYSE:RMD）的持有评级，目标价保持在250.00美元不变。这一决定是在审查了该公司2025财年第二季度的财务表现后做出的。ResMed目前的交易价格接近其52周高点263.05美元，延续了其势头，实现了略高于预期的收入和每股收益（EPS）数据。收入超预期主要归因于设备销售按固定汇率（CC）计算增长了11%，推动公司同比收入增长9.38%。这一增 ...

Q2 2025 Earnings Call Transcript January 30, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32. Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings ...

SANTA BARBARA, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- AppFolio, Inc. (NASDAQ: APPF) ("AppFolio" or the "Company"), a technology leader powering the future of the real estate industry, today ...

The global sleep software market valued at US$ 776.2 Million in 2023, is forecasted to grow at a robust CAGR of 10.1%, ...

UBS makes a similar comment, stating ResMed shares are trading at 23x FY26 earnings. Although this represents a 40% premium ...